Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DPP4 | P27487 | 14/20 | 0.39 |
| ▸ | KCNH2 | Q12809 | 4/20 | 0.39 |
| ▸ | CHRM1 | P11229 | 4/20 | 0.38 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.38 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.38 |
| ▸ | GNRHR | P30968 | 6/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6573577 | 0.80 | DPP4 (0.60) | DPP4KCNH2CHRM1CHRM2CHRM3 | |
| SCHEMBL4667081 | 0.74 | DPP4 (0.68) | DPP4KCNH2CHRM1CHRM2CHRM3 | |
| SCHEMBL4668949 | 0.73 | DPP4 (0.68) | DPP4KCNH2CHRM1CHRM2CHRM3 | |
| SCHEMBL6687759 | 0.72 | DPP4 (0.41) | DPP4KCNH2CHRM1 | |
| SCHEMBL6689878 | 0.70 | DPP4 (0.40) | DPP4KCNH2CHRM1CHRM2CHRM3 | |
| SCHEMBL6676648 | 0.67 | DPP4 (0.40) | DPP4KCNH2CHRM1CHRM2CHRM3 | |
| SCHEMBL27600204 | 0.66 | DPP4 (0.47) | DPP4KCNH2CHRM1CHRM2CHRM3 | |
| SCHEMBL4669728 | 0.66 | DPP4 (0.72) | DPP4KCNH2CHRM1CHRM2CHRM3 | |
| SCHEMBL556182 | 0.64 | DPP4 (0.65) | DPP4KCNH2CHRM1CHRM2CHRM3 | |
| SCHEMBL11907413 | 0.60 | DPP4 (0.43) | DPP4KCNH2CHRM1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1404675-A1 | DPP-IV-INHIBITING PURINE DERIVATIVES FOR THE TREATMENT OF DIABETES | NOVO NORDISK A/S (DK) | 2004-04-07 | — | — | EP | disclosed |
| WO-2003004496-A1 | DPP-IV-INHIBITING PURINE DERIVATIVES FOR THE TREATMENT OF DIABETES | NOVO NORDISK A/S (DK) | 2003-01-16 | — | — | WO | disclosed |